Sue Peschin, MHS

Articles

The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works

December 16, 2024

The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.

Dear Payers: Drugs for Early Alzheimer's Disease are ‘Worth It’

October 07, 2024

Medicare’s restrictive coverage policies are denying patients with early Alzheimer's disease access to novel treatments. And private payers are following suit.